株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Array BioPharma Inc. - 製品パイプライン分析

Array BioPharma Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 224607
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
Array BioPharma Inc. - 製品パイプライン分析 Array BioPharma Inc. - Product Pipeline Review - 2015
出版日: 2015年11月18日 ページ情報: 英文 68 Pages
概要

Array BioPharma Inc.は、癌や炎症性疾患治療のための標的小分子薬剤の開発と商品化に注力するバイオ製薬会社です。

当レポートでは、Array BioPharma Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Array BioPharma Inc.の基本情報

Array BioPharma Inc.の概要

  • 主要情報
  • 企業情報

Array BioPharma Inc.:R&Dの概要

  • 主な治療範囲

Array BioPharma Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ
  • アウトライセンス製品
    • アウトライセンス製品/併用療法モダリティ

Array BioPharma Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ
  • ■Array BioPharma Inc.:薬剤プロファイル
  • ARRY-502
  • ARRY-520
  • ARRY-797
  • ARRY-380
  • ARRY-614
  • AR-460770
  • AR-523
  • AR-786
  • ARRY-005
  • ARRY-006
  • ARRY-111
  • ARRY-981
  • Drugs Targeting Inflammation Pathway
  • Small Molecule To Inhibit B-Raf Kinase For Cancer

Array BioPharma Inc.:パイプライン分析

  • 薬効分類別
  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Array BioPharma Inc.:最近のパイプライン動向

Array BioPharma Inc.:休止中のプロジェクト

Array BioPharma Inc.:開発が中止されたパイプライン製品

  • 開発が中止されたパイプライン製品のプロファイル
    • ARRY-797
  • ■Array BioPharma Inc.:企業発表

Array BioPharma Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07697CDB

Summary

Global Markets Direct's, 'Array BioPharma Inc. - Product Pipeline Review - 2015', provides an overview of the Array BioPharma Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Array BioPharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Array BioPharma Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Array BioPharma Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Array BioPharma Inc.'s pipeline products

Reasons to buy

  • Evaluate Array BioPharma Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Array BioPharma Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Array BioPharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Array BioPharma Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Array BioPharma Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Array BioPharma Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Array BioPharma Inc. Snapshot
    • Array BioPharma Inc. Overview
    • Key Information
    • Key Facts
  • Array BioPharma Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Array BioPharma Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Array BioPharma Inc. - Pipeline Products Glance
    • Array BioPharma Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Array BioPharma Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Array BioPharma Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Array BioPharma Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Array BioPharma Inc. - Drug Profiles
    • binimetinib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • binimetinib + encorafenib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • encorafenib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • filanesib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARRY-502
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARRY-797
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pexmetinib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-460770
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-523
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-786
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARRY-981
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Inflammation
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-00457679
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARRY-111
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Kinase for Autoimmune Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Array BioPharma Inc. - Pipeline Analysis
    • Array BioPharma Inc. - Pipeline Products by Target
    • Array BioPharma Inc. - Pipeline Products by Route of Administration
    • Array BioPharma Inc. - Pipeline Products by Molecule Type
    • Array BioPharma Inc. - Pipeline Products by Mechanism of Action
  • Array BioPharma Inc. - Recent Pipeline Updates
  • Array BioPharma Inc. - Dormant Projects
  • Array BioPharma Inc. - Dormant Projects
  • Array BioPharma Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ARRY-797
  • Array BioPharma Inc. - Company Statement
  • Array BioPharma Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Array BioPharma Inc., Key Information
  • Array BioPharma Inc., Key Facts
  • Array BioPharma Inc. - Pipeline by Indication, 2015
  • Array BioPharma Inc. - Pipeline by Stage of Development, 2015
  • Array BioPharma Inc. - Monotherapy Products in Pipeline, 2015
  • Array BioPharma Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Array BioPharma Inc. - Partnered Products in Pipeline, 2015
  • Array BioPharma Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Array BioPharma Inc. - Out-Licensed Products in Pipeline, 2015
  • Array BioPharma Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Array BioPharma Inc. - Phase III, 2015
  • Array BioPharma Inc. - Phase II, 2015
  • Array BioPharma Inc. - Phase I, 2015
  • Array BioPharma Inc. - Preclinical, 2015
  • Array BioPharma Inc. - Discovery, 2015
  • Array BioPharma Inc. - Unknown, 2015
  • Array BioPharma Inc. - Pipeline by Target, 2015
  • Array BioPharma Inc. - Pipeline by Route of Administration, 2015
  • Array BioPharma Inc. - Pipeline by Molecule Type, 2015
  • Array BioPharma Inc. - Pipeline Products by Mechanism of Action, 2015
  • Array BioPharma Inc. - Recent Pipeline Updates, 2015
  • Array BioPharma Inc. - Dormant Developmental Projects,2015
  • Array BioPharma Inc. - Discontinued Pipeline Products, 2015
  • Array BioPharma Inc., Other Locations

List of Figures

  • Array BioPharma Inc. - Pipeline by Top 10 Indication, 2015
  • Array BioPharma Inc. - Pipeline by Stage of Development, 2015
  • Array BioPharma Inc. - Monotherapy Products in Pipeline, 2015
  • Array BioPharma Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Array BioPharma Inc. - Partnered Products in Pipeline, 2015
  • Array BioPharma Inc. - Out-Licensed Products in Pipeline, 2015
  • Array BioPharma Inc. - Pipeline by Top 10 Target, 2015
  • Array BioPharma Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Array BioPharma Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Array BioPharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top